Latest Competition News

American West Metals has unveiled a positive Preliminary Economic Analysis for its Storm Copper Project in Canada, outlining a low-cost, 10-year production plan with strong financial returns. The company also secured a strategic funding and offtake partnership with Ocean Partners, while advancing its critical minerals projects in the US.

Zoom2u Technologies reports steady group revenue with Locate2u growing 10%, supported by AI initiatives that cut staff costs and a $0.5 million capital raise.

RLF AgTech has secured major national distribution agreements in Australia, launched a comprehensive retail rollout, and restructured its manufacturing arm, LiquaForce, to drive growth and operational efficiency. The company also reported strong financial performance and expanded its footprint across Asia.

RooLife Group Ltd (RLG) has inked exclusive decade-long agreements with three Chinese companies to market and distribute branded solar energy systems worldwide, marking a strategic expansion into the renewable energy sector.

Constellation Technologies Limited reports sustained sales growth and positive cash flow in Q3 2025, driven by its Callisto Food Safety & Compliance system and strategic market expansion.

PEXA has achieved a crucial regulatory milestone with FCA approval to operate as an Authorised Payment Institution in the UK, paving the way for its Sale & Purchase product launch later this year.

Beonic Limited reported a 6.5% increase in annual recurring revenue to $17.8 million and a significant gross margin improvement to 75.5%, driven by new global contracts and disciplined cost management. The company targets cash flow breakeven in Q4 FY25 and an EBITDA margin of up to 15%.

Charger Metals NL reported strong progress in its lithium and gold exploration during the March 2025 quarter, supported by Rio Tinto’s $1.1 million funding at Lake Johnston and the full acquisition of the Bynoe Lithium Project. High-grade lithium intersections and promising gold targets underpin its growth strategy.

Althea Group Holdings reported $5.02 million in Q3 FY25 receipts, driven by strong growth at Peak Canada and the launch of Peak USA, while its pharmaceutical cannabis division faces steep revenue declines prompting strategic review.

Actinogen Medical advances its XanaMIA phase 2b/3 Alzheimer’s trial with faster patient enrolment and expands clinical sites, while achieving a pivotal FDA meeting outcome for its depression program. The company maintains a strong cash position, supporting ongoing development and commercialization efforts.

Syntara Limited reports significant clinical progress with its lead myelofibrosis drug SNT-5505 and launches a new trial for its next-generation anti-fibrotic skin treatment, supported by a solid $18 million cash reserve.

Opthea Limited has discontinued its wet AMD development program following Phase III trial failures, slashing its workforce by 65% amid ongoing financial uncertainty and negotiations with investors.